12 funding opportunities found in this category. Change the order of results:
Lowest Award to Highest
Highest Award to Lowest
Call for Applications: 2014 NARSAD Independent Investigator Grant
The Brain & Behavior Research Foundation is now accepting online applications for the 2014 NARSAD Independent Investigator Grant.
Applications must be submitted by Tuesday, December 31, 2013, 11:59 p.m. Eastern
Submit your application as early as possible to avoid any last-minute technical complications that may arise with your submission.
The Brain & Behavior Research Foundation is the largest non-government, donor-supported organization that distributes funds for brain and behavior disorder research.
The Brain & Behavior Research Foundation NARSAD Independent Investigator Grant offers up to $50,000 a year for two (2) years and is intended for scientist at the associate professor level (or equivalent) with national competitive supports as a principal Investigator (P.I.).
Please note that an assistant professor who is a Principal Investigator (P.I.) on a NIH R01 grant is now eligible for the Independent Investigator Grant. The Independent Investigator Grant stands between the Young and Distinguished Investigator Grants. The Young Investigator is intended to extend initial research training, or support scientists at the assistant professor rank. The Distinguished Investigator supports senior investigators (full professor or equivalent) pursuing innovative, new directions. Strict adherence to eligibility guidelines for the Independent Investigator will apply to prevent overlap between the programs, and to ensure that a reasonable proportion of applications judged to be excellent can be funded.
The program is intended to facilitate innovative research opportunities and supports basic, as well as translational and/or clinical investigators, however, research must be relevant to understanding, treatment and prevention of serious psychiatric disorders such as schizophrenia, mood disorders, anxiety disorders, or early onset brain and behavior disorders.
As is well known, the Brain & Behavior Research Foundation is interested in supporting the full range of relevant neurobiological and psychobiological basic science. We also support clinical grants which can include careful studies using qualitative research approaches or research generating preliminary data to explore a new hypothesis generated by clinical experience or large sample studies. NARSAD Grants are not sufficient to support expensive large sample patient-based studies but it may be possible to attach a study to a clinical project already under way or for which other funding has become available. Some possibilities for preliminary clinical studies include:
1. Support for an add-on study to identify a biomarker in the context of an ongoing clinical trial.
2. Determining if a computer-based cognitive or other remediation enhances effectiveness of a treatment.
3. Proof of principle study in a small number of subjects to see if efficacy is detected with a new treatment.
4. Testing a novel hypothesis within an already established data set.
5. Research on productive work and other treatment outcomes.
These examples do not define specific Brain & Behavior Research Foundation goals, but illustrate feasibility of
expensive clinical research in the context of the NARSAD Grants program.
The Brain & Behavior Research Foundation is committed to spending all contributions for direct research support. Operational expenses are generously underwritten by two family foundations. Administrative cost is small—reviewers are Scientific Council members and volunteer their time; therefore, no feedback can be provided.
Request for Applications: Innate Immune System Impact
The Simons Foundation Autism Research Initiative (SFARI) seeks to improve the diagnosis and treatment of autism spectrum disorders by funding innovative research of the highest quality and relevance.
Objective of the Innate Immune System Impact Award
Grants awarded through this Request for Applications (RFA) are intended to advance our understanding of the impact of activation of the innate immune system on behavioral, circuit, synaptic and neuronal functions in order to understand the consequences of infection and immune activation on autism-related behaviors.
To this end, we seek applications for investigations of the impact of physiologically relevant activation of the innate immune system on behavioral, circuit, synaptic and neuronal functions in animal models of autism. SFARI especially encourages applications that address either of the following two issues:
(1) Effects of activation of the maternal innate immune system on embryonic central nervous system development in genetic models of autism and controls. How do fetal genetics and maternal innate immune activation interact to affect postnatal autism-related phenotypes, and what are the mechanisms through which they interact?
(2) Effects of activation of the innate immune system in genetic autism models and adult controls. How does innate immune activation affect behavioral, circuit, synaptic and cellular function in these genetic models and in controls? What are the roles of cytokine signaling, fever, immune cell activation and other effectors on these functions?
SFARI prioritizes animal models with strong construct validity based on human genetic studies of autism. To this end, SFARI is currently funding systematic behavioral testing on select mouse models and increasing their availability to the broader scientific community through The Jackson Laboratory in Bar Harbor, Maine. Investigators are strongly encouraged to consider using this resource when developing their experimental plans. Given the breadth of knowledge about the genetics of autism, SFARI expects and encourages most applicants to focus on genetic autism and/or innate immunity mouse models, but other models may be proposed if the application contains a compelling rationale based on strong evidence from human studies.
Eligibility and collaboration
All applicants and key collaborators must hold a Ph.D., M.D. or equivalent degree and have a faculty position or the equivalent at a college, university, medical school or other research facility. Applications may be submitted by domestic and foreign nonprofit organizations; public and private institutions, such as colleges, universities, hospitals, laboratories, units of state and local government; and eligible agencies of the federal government. There are no citizenship or national residence requirements.
If the proposal includes investigators at more than one site, all investigators should have demonstrated prior success in similar collaborations.
Funding period and budget
The grant period is for three (3) years. Continued funding is possible, when justified by scientific progress. During this initial three-year period, SFARI plans to commit up to $1 million annually to support projects funded as a result of this RFA.
Applications should include the following:
1. Narrative, not exceeding six (6) pages (excluding references and figures). Proposals should include specific aims, background relevant to the application, significance of the proposed studies, preliminary results, experimental design, pitfalls and alternative strategies, relevance to autism, and a timeline with milestones.
2. Biosketches for Principal Investigator(s) and Key Collaborators. The investigative team should include members with strong expertise in the physiological recordings and behaviors they propose in their application.
3. Current and pending support for Principal Investigator(s) and Key Collaborators.
4. Budget. While there are no budget caps on the individual applications, budgets will strongly factor into the competitiveness of an application. Budgets of more than $250,000 annually will need convincing justification. It is unlikely that SFARI will make an award larger than this amount. Proposals should include a realistic budget sufficiently detailed for evaluation of needed resources. SFARI will work closely with investigative teams with competitive applications to arrive at a suitable budget. Indirect costs are limited to 20 percent of the modified total direct costs.
Applications with multiple Principal Investigators from different institutions that would like to be paid separately must include a signed budget template and budget justification for each Principal Investigator’s institution. Applications with subcontracts must include a budget and budget justification. The budget template and budget justification are available for download in the proposal attachments section of proposalCENTRAL’s full application.
5. Research environment and resources. Investigators should demonstrate access to appropriate resources for high-capacity data collection and analysis, although SFARI will work with awarded investigative teams to provide additional informatics support as needed.
6. Data-sharing plan. The plan should include sharing of raw and analyzed data. SFARI will work closely with awarded investigative teams to ensure that the final plan includes timely dissemination of data with reasonable embargo provisions.
For more details, see the Instructions document, which is available for download in the proposal attachments section of proposalCENTRAL.
The deadline for full proposal submission is 3 March 2014, 5 p.m. Eastern. No extensions will be given. If you have any difficulties, please contact email@example.com.
Competitive applications will receive external peer review. SFARI will make final funding decisions; notification of award is expected by 1 July 2014, with funding expected to begin 1 August 2014.
Instructions for submission
Applications must be completed electronically and submitted using forms provided at proposalCENTRAL. Please log in as an applicant, scroll to ‘Simons Foundation’ and click on the program.
Parkinson’s Disease Foundation-Parkinson Study Group Mentored Clinical Research Award
The Mentored Clinical Research Award (MCRA) for new investigators is funded by a grant from the Parkinson’s Disease Foundation (PDF) to the Parkinson Study Group (PSG). The grant supports new investigators for a one-year project in patient-oriented research in Parkinson’s disease or other parkinsonian disorders under the mentorship of an experienced investigator. The goal of the award is to provide funding for an investigator who has the potential to become an independent researcher.
It is anticipated for the current application period that an award of $50,000 will be available. Only direct costs will be funded by this award.
Eligibility & Restrictions
Applicants for the MCRA should be clinicians and scientists who are within five years of having completed formal training. Fellows may apply. If during formal training unusual circumstances occurred to delay completion, “time out” periods will be permitted and should be explained in the application cover letter.
Applicants must identify an appropriate mentor or mentors with extensive research experience. Either the applicant or the mentor must be a member of the PSG. An applicant may have co-mentors.
Proposals for the MCRA are due on Friday, January 3, 2014, to be considered for funding. Please note that this is a collaborative fellowship and for this program, applicants cannot use PDF's online grant management system. Instead, applicants should submit an electronic copy of the proposal in Microsoft Word of .pdf format to the PSG to Roseanna.Battista@ctcc.rochester.edu with a cover note that includes the candidate’s name and the title of proposal.
Proposals should be hypothesis driven and amenable to completion in a one year time period. The proposal should be directed toward patient oriented research in Parkinson’s disease or related parkinsonian disorders.
All applications for this fellowship should include the following elements:
The focus of the proposal must relate to an area of importance in the field. The research plan should address unmet needs of people living with PD, have the potential for broad application among the PD community, and lead to advances in clinically relevant treatment options;
A research proposal (five pages in length) including an abstract, specific aims, background and significance, preliminary studies and experimental designs and methods;
A clear description of the educational plan that will be implemented to educate the candidate in development of appropriate research methodology under the direction of the mentor;
A statement of the qualification of the mentor(s) to guide the research program.
An electronic copy of the proposal in Microsoft Word or pdf-format;
The candidate’s proposal should be formatted according to the guidelines indicated on the PSG website.
The research plan itself should not exceed five pages. The candidate should also include a four-page NIH-style biosketch and other support statement for both the applicant and the mentor(s);
The proposal should include a statement from the mentor(s) including information on research qualifications.
The statement should include the nature of the supervision that will occur during the award period and an agreement to provide mentorship to the candidate for the award period. The mentor must include information on what skills they plan to teach the mentee and how previous fellows they mentored are contributing to Parkinson’s research (if applicable);
A budget and brief budget justification are required for all funds requested. No indirect costs will be funded;
The funding request should not exceed $50,000;
Clinical research proposals need not be pre-approved by institutional IRB, but should include a Human Studies section that addresses concerns pertaining to risk, benefit and consent (not included in the five page limit);
Revised applications should include an Introduction of not more than one page that describes how the applicant has responded to the reviewers’ criticisms.
Review & Decisions
Proposals received within the specified time frame are reviewed by the PSG Mentoring Committee. Applicants will be notified of the results on Monday, March 3, 2014. Funding will begin on July 1 and continue until June 30.
Successful applicants will be required to submit a short written summary of progress at six months and at one year after funding and attend the annual PSG meeting to present the results of the research done during their fellowship year. The meeting expense will be supported by the PSG separately from the grant award.
Parkinson's Disease Foundation Summer Student Fellowships
Applications due: Monday, January 27, 2014
PDF’s Summer Fellowship Program is used to support students – from advanced undergraduates to graduate and medical students – in their pursuit of Parkinson's-related summer research projects. The goal of the Summer Fellowship is to cultivate an early interest in Fellows into the cause and possible treatments for Parkinson's disease.
Fellows work under the close supervision of a sponsor who is an expert in the Parkinson's community and oversees the project. Typically, summer fellowships are offered for 10 weeks of clinical or laboratory work with an award of $4,000.
The award is to be used to support the student's summer research, for example, to defray tuition costs of research credits or to supplement living/housing costs. This award may taxable; an IRS form 1099 will be sent to the recipient at the end of the calendar year.
Undergraduate students, graduate students and medical students are all eligible for summer fellowships. Each applicant must identify a mentor with whom he or she will conduct the proposed project. This program is open to both national and international applicants.
Please note that this year, all applications must be submitted online through the PDF website at grants.pdf.org; no paper copies will be accepted. This application period typically opens in December closes at the end of January. Successful applicants are typically notified in mid-April of PDF's decisions.
Briefly, a complete application will consist of the following five items:
Brief, two-page proposal describing the research plan (written by applicant in conjunction with mentor);
Copy of the student’s academic transcript (unofficial is acceptable);
Statement by the applicant, describing why he or she is interested in conducting Parkinson's research, his or her qualifications, and the relevance of this research to his or her career/research interests;
Letter of support, written by the mentor under whom the applicant plans to work, discussing qualifications of the student, affirming that facilities and materials will be available and agreeing to actively guide the student’s work. This letter must be sent separately by the mentor either via email to firstname.lastname@example.org with “SUMMER FELLOWSHIP” in the subject line or via regular mail to Parkinson’s Disease Foundation; Summer Fellowship Letter of Support; Attn: Dr. Beth Vernaleo, Grants Manager; 1359 Broadway, Suite 1509, New York, NY 10018.
All letters must be received by the application deadline.;
Application form, completed.
Note: Incorrect or incomplete applications will be rejected without comment.
Applications are judged based on the feasibility of the applicant's project, the background of the applicant and the appropriateness of the mentor. Final decisions are typically made in mid-April. PDF will contact all candidates at that time. Funding for successful applicants may commence as early as June 1.
New Investigator Awards in Alzheimer's Disease
Funded by The Rosalinde and Arthur Gilbert Foundation and The Diane and Guilford Glazer Foundation, the major goal of this partnership program is to support important research in areas in which more scientific investigation is needed to improve the prevention, diagnosis, and treatment of Alzheimer's disease. The program also serves to encourage junior investigators in the United States and Israel to pursue research and academic careers in the neurosciences, and Alzheimer's disease in particular.
Projects in basic and translational research related to Alzheimer's disease (AD) that are clinically relevant, will be considered. Projects that focus on healthy brain aging are also considered. For one of the awards, priority may be given to an investigator with a research interest related to healthy brain aging. Areas of research could for example include learning and memory, nutrition, exercise, cardiovascular risk factors, as they relate to the brain and the aging process.
Examples of promising areas of research include, but are not limited to:
Basic mechanisms of aging in the central nervous system
Learning and memory
The Biology and Pathobiology of Synapses
Genetics of AD
Neuroimaging and precursors of AD
Cellular and Molecular pathways of AD
Biological Markers of AD
Exercise, nutrition and dietary factors
Neurogenesis and AD
Impact of environmental agents in CNS aging and early AD
Cardiovascular and cerebrovascular factors
It is anticipated that up to 4 grants of $100,000 each will be awarded in 2014. Applicants may propose to use the award over the course of one or two years as justified by the proposed research. Up to 8% of funds may be budgeted for overhead or indirect costs (not to exceed $7,407). Funding will begin July 1, 2014.
The applicant must be an independent investigator with independent research space as described in a form completed by the Dean or Department Chair, and must be no more than 10 years beyond start of postdoctoral research training as of July 1, 2014. Exceptions to the ten year rule may be requested for unusual circumstances by emailing an NIH-style biosketch to AFAR at email@example.com. The proposed research must be conducted at any type of not-for-profit setting in the United States or Israel.
The New Investigator Awards in Alzheimer's Disease do not provide support for:
Postdoctoral fellows in the laboratory of a senior investigator
Investigators who have already received major extramural funding (such as an R01 or NSF equivalent grant)
Senior faculty, i.e. at the rank of Associate Professor level or higher
NIH Intramural program employees
Applicants who are conducting research at a for-profit institution, or at an institution outside of the United States or Israel
Applicants cannot apply for the 2014 AFAR Research Grant Program or Glenn/AFAR BIG Program. Applications for this program will be considered for the AFAR Research Grant if deemed competitive.
Five criteria are used to determine the merit of an application:
Qualifications of the applicant;
Quality of the proposed research;
Relevance of the proposal to how mechanisms of aging may lead to AD or encourage healthy brain aging;
Excellence of the research environment;
Likelihood that the project will advance the applicant's career in basic research on the mechanisms of aging and AD or healthy brain aging
For one of the awards, priority may be given to an investigator with a research interest related to healthy brain aging provided the application is deemed to meet the highest standards set by AFAR's Research Committee.
The deadline for receipt of all Letters of Intent is December 16, 2013 at 5:00 p.m. EST. Please refer to the New Investigator LOI instructions. Incomplete LOIs cannot be considered. All applications and supporting materials must be submitted through the website www.afar.org/grants/. The Letters of Intent will be reviewed by a committee. Applicants will be notified by January 31, 2014, and a subset of applicants will be invited to submit a full application by March 17, 2014.
All LOI candidates who are invited to submit applications must have it endorsed by their institution. Final awards are announced by early June. The award start date is July 1, 2014. AFAR will not provide reviewer critiques to any applicants at any review level.
Investigators will be required to submit a brief narrative report on the progress of their research five months after the start date of the award. Final narrative and financial reports are required within three months following the end date of the award.
The award recipients are expected to attend the AFAR Grantee Conference which convenes AFAR grant recipients, mentors and leaders in the field to review and disseminate the research progress of the grantees and their findings. The meeting encourages networking, facilitates collaborations, and enhances the development of leadership. In addition, grant recipients of the New Investigator Awards in Alzheimer's are expected to attend a special session at the grantee conference.
Parkinson Study Group Mentored Clinical Research Award for New Investigators in Patient-Oriented Research in Parkinson’s Disease and Related Disorders
The Mentored Clinical Research Award (MCRA) for new investigators is funded by a grant from the Parkinson’s Disease Foundation (PDF) to the Parkinson Study Group (PSG). The purpose of this grant is to support a new investigator for a 1 year project in patient oriented research in Parkinsons disease or other parkinsonian disorders under the mentorship of an experienced investigator. The goal of the Award is to provide funding for an investigator with the potential to become an independent researcher. Appropriate applicants for the MCRA are clinicians and scientists who are within 5 years of having completed formal training. The applicant must identify an appropriate mentor or mentors with extensive research experience. Either the applicant or the mentor must be a member of the PSG.
Application deadline: Friday, January 3, 2014
Award available: $50,000
Notification of award: March 3, 2014
McKnight Endowment Fund for Neuroscience Scholar Award
Applications for the McKnight Endowment Fund for Neuroscience Scholar Award due January 6, 2014.
The McKnight Endowment Fund for Neuroscience supports innovative research designed to bring science closer to the day when diseases of the brain can be accurately diagnosed, prevented, and treated. To this end, the McKnight Endowment Fund for Neuroscience invites applications for the 2014 McKnight Scholar Awards.
These awards were established to encourage emerging neuroscientists to focus on disorders of learning and memory. Applicants for the McKnight Scholar Awards must demonstrate interest in solving important problems in relevant areas of neuroscience, including the translation of basic research to clinical neuroscience. Awards are given to exceptional young scientists who hold the M.D. and/or Ph.D. degree and who are in the early stages of establishing an independent laboratory and research career. Traditionally, successful candidates have held faculty positions for at least one year. Up to six McKnight Scholars each will receive three years of support, beginning July 1, 2014.
Eligibility. Applicants must have the following:
• an M.D. and/or Ph.D. degree and have completed formal postdoctoral training;
• tenure-track status at a U.S.-based sponsoring institution, to which awards will be paid;
• a record of meritorious research in areas pertinent to the interests of the Endowment Fund;
• no more than four years of experience in an independent/tenure-track faculty position (exceptions may be made to account for parental leave);
• evidence of a commitment to a career in neuroscience; and
•U.S. citizenship or lawful permanent resident status.
Please note: applicants must be in a tenure-track position; research faculty with annually renewable contracts are not eligible.
Applicants may not:
• be employees of the Howard Hughes Medical Institute or scientists within the intramural program of the National Institutes of Health;
• apply in more than two rounds of competition;
• apply for continued postdoctoral support;
• be tenured already; or
• hold another McKnight award.
Amount and Purpose of Support. Each McKnight Scholar will receive $75,000 annually in 2014, 2015, and 2016. Funds may be used in any way that will facilitate development of the Scholar’s research program, but not for indirect costs.
Selection Process. A review committee will evaluate applications and invite a select few to interview with the committee. Applicants selected will be notified by March 28, 2014. The interviews are scheduled for Friday, April 25, 2014 in New York City. The committee will then recommend candidates to the Board of Directors of the Endowment Fund for final decision. Awards will be announced on or before May 17, 2014.
Filing of Scholar Award Application. Applications must arrive no later than January 6, 2014. Please email one PDF of the completed application to firstname.lastname@example.org (references will be submitted separately). If you do not receive confirmation of receipt within a week of submission, please call Eileen at 612-333-4220.
Michael J. Fox Foundation for Parkinson's Research Target Validation Program
Fall 2014 Review Cycle
Informational Conference Call*: March 26, 2014 at 12pm US ET
Pre-proposals Due: May 28, 2014 – 6pm US ET
Full Proposal Invitations: June 18, 2014
Full Proposals Due (by invite only): August 6, 2014 – 6pm US ET
Anticipated Award Announcement: October 2014
Anticipated Funding: November 2014
*MJFF will hold a 45-minute conference call on the dates and times listed above to clarify and explain the goals of this funding initiative and answer applicant questions. To participate in the call and receive call-in details, please RSVP via email to email@example.com.
The Target Validation program supports work to determine whether manipulation of a defined biological target provides a disease-relevant beneficial outcome in a whole animal, mammalian model of PD. MJFF does not have any pre-conceived preferences for particular targets submitted to the Target Validation program. However, we recommend applicants consider the following:
The target should be clearly defined, such as:
A specific gene
A structural/functional feature of a protein (e.g., its enzymatic activity, protein conformation or ability to interact with other proteins)
Proposals seeking to manipulate global pathways without a clear target are not encouraged
Applicants may propose a variety of methods to manipulate a target, including but not limited to:
Use of pharmacological tools
Supporting data/explanation of the proposed pharmacological tool must be addressed in the body of the proposal.
Parameters that should be discussed include:
Selectivity for the target of interest
Pharmacokinetic/Pharmacodynamic measures that have been/will be assessed
Measures of target engagement
Use of biologic strategies such as:
Viral vector-mediated gene delivery, etc.
In Vivo Models
Applicants may also propose use of models appropriate for the target proposed including:
Previously established genetically engineered animal models including:
Knockout models where the target/gene of interest is deleted
Transgenic models whereby the target/gene of interest is over-expressed
Investigators should proposed to examine PD-relevant features or sensitivity to PD-associated factors during the course of their studies
Proposals may include intermediate tests using in vitro, ex vivo and/or model organisms (e.g., Drosophila, C. elegans) to optimize the ideal target manipulation strategy
These proposals must ultimately include within the grant funding period an evaluation of the target manipulation in a whole-animal mammalian model of PD
Note: The following types of proposals are not appropriate for the Target Validation program:
Proposals focused on new target identification and proposals testing cellular transplantation approaches.
Proposals seeking to generate new genetic (knockin, knockout, transgenic) models
Investigators seeking guidance to develop new models around their target are encouraged to contact firstname.lastname@example.org
Applicants seeking support for therapeutic development should submit to the Therapeutic Pipeline Program or contact MJFF research staff for guidance.
MJFF will commit up to $10 million to the Edmond J. Safra Core Programs for PD Research with the intention to support multiple awards. The Target Validation program supports two-year grants up to $250,000 total costs inclusive of both direct and indirect costs. The total annual direct costs cannot exceed $100,000. No more than 25% (Academic institutions) or 10% (for-profit organizations) of the direct costs may go to indirect costs.
Applications may be submitted by:
U.S. and non-U.S. biotechnology/pharmaceutical companies or other for-profit entities, either publicly or privately held,
U.S. and non-U.S. entities, public and private non-profit entities, such as universities, colleges, hospitals, laboratories, units of state and local governments, and eligible agencies of the federal government.
Post-doctoral fellows are NOT eligible to apply as Principal Investigators to the Target Validation program.
Call for Nominations: Barancik Prize for Innovation in Multiple Sclerosis Research
The Barancik Prize for Innovation in Multiple Sclerosis Research recognizes an exceptional scientist or a team of scientists whose work in MS research has demonstrated outstanding innovation and originality. This annual prize, made possible by the generosity of the Charles and Margery Barancik SO Foundation, is $100,000 to be used at the discretion of the recipient.
Criteria and Nominations
The goal of the prize is to recognize innovation in scientific research in the field of multiple sclerosis. Nominations must be submitted on behalf an individual, or team of individuals, by one or more colleagues or mentors. Self-nominations are not permitted. Nomination letters should include current institution and contact information of the nominee, and should address the nominee’s scientific accomplishments with an emphasis on citing the innovative and impactful aspects of the nominee’s work. A selection committee comprised of leaders in science, medicine, and MS advocacy will review nominees. The committee will evaluate:
• Exceptional innovation and originality in scientific research relevant to MS
• Impact and potential of the research to lead to pathways for the treatment and cure for MS
• Scientific accomplishments that merit recognition as a future leader in MS research
Nominees that exhibit these qualities will be invited to submit a final application that will include an interview by the selection committee.
Any investigator(s) active in MS research is eligible for the prize, and the nominee(s) may be from any institution or organization— public or private, government, as well as commercial entities. Nominees may also be at any stage of their professional career in MS research. There are no specific requirements for residency or citizenship. Nominees need not be current or past grantees of the National MS Society.
Nomination letters should be sent to email@example.com starting November 1, 2013 until the January 31, 2014 deadline to be considered for the 2014 prize. Notification of the recipient shall occur by June 2014 followed by a public announcement.
Walter G. McMillen Memorial Award for Parkinson’s Disease Research
The Walter G. McMillen Memorial award is designed to encourage graduate student’s interest in research on Parkinson’s disease.
Potential research topics that will be funded by this award include, but are not limited to:
The assessment and treatment of persons with Parkinson’s disease.
The impact of this diagnosis on family support systems (e.g., caregiver burden).
For the purposes of this award, the term "research" is broadly defined to include any scholarly endeavor, including but not limited to experiments, correlational studies, qualitative investigations, historical work, case studies, and evaluation research.
However, the focus of this research must be on the assessment, treatment, or management of Parkinson’s disease.
The cash award of $1,000 is intended to offset direct costs associated with the planned research. These may include salaries, equipment, supplies, stipends for study participants, etc.
Note that the monies will be awarded to the candidate’s institution and not directly to the applicant.
Indirect costs are not supported by this award. Candidates should contact their grants office to ensure that indirect costs can be waived prior to applying for this award.
Annual deadline: March 15
The award competition is open to doctoral-level graduate students.
Only one submission per student will be reviewed each year.
The funded research proposal is expected to be conducted during the next academic year.
To be eligible for this award, the student must initiate and conduct the project under the supervision of a professor or research advisor. The applicant is expected to be the principal investigator on the project.
How to Apply
Research proposals should include:
An abstract (up to 400 words)
A research plan (not to exceed five pages using 12-point font or larger), including:
• Specific aims/hypotheses
• Background and significance
• Research design and methods
• How the grant funds will be used
• Cited literature
Applicants must also submit:
A biographical sketch (not to exceed one page), that includes in list format:
• Schools attended with degrees attained
• Relevant professional position
• Society memberships
• Publications and/or paper presentations
• Relevant coursework
• Any other relevant information you would like to include
A short supporting statement by the faculty sponsor verifying the nature of and the relative contribution to the research by the student submitting the proposal. This statement should be short, not to exceed one paragraph, and emailed directly from the advisor.
Please submit applications electronically as an email attachment to the co-chair of the Awards Committee. Type "McMillen Award Submission" in the subject line of the email.